Skip to main content
. Author manuscript; available in PMC: 2012 Mar 8.
Published in final edited form as: Circulation. 2011 Feb 21;123(9):961–970. doi: 10.1161/CIRCULATIONAHA.110.943019

Table 1.

Peak/trough phase locations and amplitudes of circadian rhythms. Data are presented as Mean±SE. Results were calculated from the cosinor fits (Figure 6) that were obtained from the cosinor analyses using the mixed model ANOVAs (Supplemental Table IV).

Baseline Tilt P (circadian)

SBP (mmHg) Peak phase 231.7°±11.8° 254.1°±9.6° 0.0079
Trough phase 340.7°±15.2° 357.7°±9.4°

Peak-to-trough amplitude 4.6±1.5 5.6±1.5

Tilt effect -2.6±0.6

DBP (mmHg) Peak phase 233.3°±26.4° 275.5°±9.1° 0.012
Trough phase 119.2°±27.4° 173.6°±10.6°

Peak-to-trough amplitude 1.9 ±1.1 3.9 ±1.1

Tilt effect 9.3 ±0.4

HR (bpm) Peak phase 189.8°±24.4° 177.0°±10.9° <0.0001
Trough phase 318.1°±22.5° 55.0°±18.2°

Peak-to-trough amplitude 5.9±2.2 8.9±2.2

Tilt effect 25.9±0.9

SDNN (msec) Peak phase 35.6°±8.9° 345.9°±19.0° <0.0001
Trough phase 265.0°±21.4° 228.4°±14.1°

Peak-to-trough amplitude 25.3±4.8 15.2±5.0

Tilt effect -25.5 ±2.0

Epinephrine (pg/ml) Peak phase 217.2°±25.5° 208.7°±11.7° <0.0001
Trough phase 328.7°±20.4° 329.3°±9.0°

Peak-to-trough amplitude 10.6±5.5 28.6±5.4

Tilt effect 25.0±2.2

Norepinephrine (pg/ml) Peak phase 120.9°±28.9° 202.3°±13.4° 0.00023
Trough phase 352.2°±36.9° 324.5°±15.3°

Peak-to-trough amplitude 40.7±20.8 81.7±21.1

Tilt effect 163.9±8.7

RMSSD (msec) Peak phase 8.8°±25.3° 113.8°±26.6° 0.00048
Trough phase 203.6°±29.7° 221.7°±21.1°

Peak-to-trough amplitude 17.9 ±4.2 8.6±5.0

Tilt effect -41.5±2.0

pNN50 (%) Peak phase 5.7°±69.1° 96.8°±48.5° 0.0026
Trough phase 188.3°±21.7° 220°±43.7°

Peak-to-trough amplitude 10.6 ±2.8 4.1±3.3

Tilt effect -31.9±1.4